BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38431053)

  • 1. Icaritin activates p53 and inhibits aerobic glycolysis in liver cancer cells.
    Zhou X; Wu D; Mi T; Li R; Guo T; Li W
    Chem Biol Interact; 2024 Apr; 392():110926. PubMed ID: 38431053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
    Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
    BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells.
    Dai Q; Yin Y; Liu W; Wei L; Zhou Y; Li Z; You Q; Lu N; Guo Q
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1468-78. PubMed ID: 23612020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway.
    Huang Q; Li J; Xing J; Li W; Li H; Ke X; Zhang J; Ren T; Shang Y; Yang H; Jiang J; Chen Z
    J Hepatol; 2014 Oct; 61(4):859-66. PubMed ID: 24801417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerobic glycolysis and tumor progression of hepatocellular carcinoma are mediated by ubiquitin of P53 K48-linked regulated by TRIM37.
    Ge Y; Zhao R; Li B; Xiao B; Zhou L; Zuo S
    Exp Cell Res; 2022 Dec; 421(2):113377. PubMed ID: 36252649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabonomics applied in exploring the antitumour mechanism of physapubenolide on hepatocellular carcinoma cells by targeting glycolysis through the Akt-p53 pathway.
    Ma T; Fan BY; Zhang C; Zhao HJ; Han C; Gao CY; Luo JG; Kong LY
    Sci Rep; 2016 Jul; 6():29926. PubMed ID: 27416811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective anti-tumor activity of wogonin targeting the Warburg effect through stablizing p53.
    Zhao Y; Zhang L; Wu Y; Dai Q; Zhou Y; Li Z; Yang L; Guo Q; Lu N
    Pharmacol Res; 2018 Sep; 135():49-59. PubMed ID: 30031170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells.
    Zhao K; Zhou Y; Qiao C; Ni T; Li Z; Wang X; Guo Q; Lu N; Wei L
    J Hematol Oncol; 2015 Apr; 8():41. PubMed ID: 25902914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of ROS and DNA damage-dependent senescence by icaritin contributes to its antitumor activity in hepatocellular carcinoma cells.
    Wang S; Wang Q; Wang H; Qin C; Cui X; Li L; Liu Y; Chang H
    Pharm Biol; 2019 Dec; 57(1):424-431. PubMed ID: 31407933
    [No Abstract]   [Full Text] [Related]  

  • 10. Retinoic acid-related orphan receptor alpha reprograms glucose metabolism in glutamine-deficient hepatoma cells.
    Byun JK; Choi YK; Kang YN; Jang BK; Kang KJ; Jeon YH; Lee HW; Jeon JH; Koo SH; Jeong WI; Harris RA; Lee IK; Park KG
    Hepatology; 2015 Mar; 61(3):953-64. PubMed ID: 25346526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma.
    Lei S; Yang J; Chen C; Sun J; Yang L; Tang H; Yang T; Chen A; Zhao H; Li Y; Du X
    J Exp Clin Cancer Res; 2016 May; 35():79. PubMed ID: 27178057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia-inducible factor-1 in human hepatoma HepG2 cells.
    Dai Q; Yin Q; Wei L; Zhou Y; Qiao C; Guo Y; Wang X; Ma S; Lu N
    Mol Carcinog; 2016 Aug; 55(8):1275-89. PubMed ID: 26259145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer agent icaritin induces apoptosis through caspase-dependent pathways in human hepatocellular carcinoma cells.
    Sun L; Peng Q; Qu L; Gong L; Si J
    Mol Med Rep; 2015 Apr; 11(4):3094-100. PubMed ID: 25434584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation.
    Eleftheriadis T; Pissas G; Antoniadi G; Spanoulis A; Liakopoulos V; Stefanidis I
    Int Immunol; 2014 Dec; 26(12):673-84. PubMed ID: 25064493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indole-3-Carbinol Stabilizes p53 to Induce miR-34a, Which Targets LDHA to Block Aerobic Glycolysis in Liver Cancer Cells.
    Qi Y; Zhang C; Wu D; Zhang Y; Zhao Y; Li W
    Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An oral 2-hydroxypropyl-β-cyclodextrin-loaded spirooxindole-pyrrolizidine derivative restores p53 activity via targeting MDM2 and JNK1/2 in hepatocellular carcinoma.
    Gao X; Wei M; Shan W; Liu Q; Gao J; Liu Y; Zhu S; Yao H
    Pharmacol Res; 2019 Oct; 148():104400. PubMed ID: 31425749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53.
    Zhou Y; Niu W; Luo Y; Li H; Xie Y; Wang H; Liu Y; Fan S; Li Z; Xiong W; Li X; Ren C; Tan M; Li G; Zhou M
    Cancer Sci; 2019 Mar; 110(3):939-949. PubMed ID: 30618169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Icaritin induces apoptosis of HepG2 cells via the JNK1 signaling pathway independent of the estrogen receptor.
    He J; Wang Y; Duan F; Jiang H; Chen MF; Tang SY
    Planta Med; 2010 Nov; 76(16):1834-9. PubMed ID: 20560114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA.
    Hua S; Liu C; Liu L; Wu D
    Biochem Biophys Res Commun; 2018 Feb; 496(3):947-954. PubMed ID: 29360449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma.
    Zhang B; Wang X; Deng J; Zheng H; Liu W; Chen S; Tian J; Wang F
    Cancer Lett; 2019 Sep; 459():50-58. PubMed ID: 31163195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.